Business
Summit Therapeutics to Present at H. C. Wainwright & Co. Global Life Sciences Conference
Summit Therapeutics plc(‘Summit' or the ‘Company')Summit Therapeutics to Present at H. C. Wainwright & Co.Global Life Sciences ConferenceOxford, UK, and
About this update from Summit Therapeutics Inc.
[{"type":"text","content":"Summit Therapeutics plc(‘Summit' or the ‘Company')Summit Therapeutics to Present at H. C. Wainwright & Co.Global Life Sciences ConferenceOxford, UK, and Cambridge, MA, US, 2 April 2019 - Summit Therapeutics plc (NASDAQ: SMMT, AIM:SUMM), a leader in new mechanism antibiotic innovation, announces that Mr Glyn Edwards, Chief Executive Officer, will present at the H. C. Wainwright & Co.Global Life Sciences Conference on 8 April 2019 at 4:10pm BST in London.A live webcast of the presentation will be available in the Investors section of the Company's website, www.summitplc.com. A replay of the webcast will be available from the same location soon after the live presentation.About Summit TherapeuticsSummit Therapeutics is a leader in antibiotic innovation. Our new mechanism antibiotics are designed to become the new standards of care for the benefit of patients, and create value for payors and healthcare providers. We are currently developing new mechanism antibiotics for C. difficile infection and gonorrhoea and are using our proprietary Discuva Platform to expand our pipeline. For more information, visit www.summitplc.com and follow us on Twitter @summitplc.Contacts-END-Source: Summit Therapeutics plc","length":1994,"tagName":"div"}]